Vinati Organics Ltd Q2 FY2027 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/bgfq7y178od49s66gnnn3le4.pdf

Key Takeaways


ATBS: The Delayed Recovery

Vinati Saraf Mutreja: "In fact, we are seeing a meaningful improvement in volumes, with Q3 itself looking strong, with an uptick in demand for ATBS. So we definitely are going to see some recovery through the second half."

Margin Pressure & the Pass-Through Gap

Gulshan Sakhuja: "You can say the worst is now behind us."

VOPL: Delayed Again, Smaller Near-Term Contribution


New Capex: Two Tranches, Adjacent Chemistry

Vinati Saraf Mutreja: "These products are related to our existing products. There is some sort of integration, some sort of adjacencies, whether backward, forward, or horizontal. We have been testing these products over the last year, so we are quite confident in implementing them, and hence we have announced them."

Segment-Level Performance

SegmentTrendCommentary
ATBS▼ Soft H1, ▲ H2 expectedDestocking delayed the recovery; meaningful volume improvement seen entering Q3, with better volumes expected through H2 and into next year.
Butyl Phenol▬ StableDelivered stable performance; better performance anticipated in H2 supported by improving demand conditions.
Antioxidant▲ StrongDelivered strong performance in H1 despite a challenging market environment; expected to maintain momentum in H2 supported by market expansion.
IB▲ StrongReported strong performance during H1; strong performance expected to continue in H2.
IBB▲ StrongDelivered strong performance in H1 in terms of both volume and pricing; similar strong performance expected in H2.
VOPL▼ DelayedInternal production problems and re-engineering pushed the ramp-up out; FY27 revenue guided to ₹75 cr–₹100 cr, with meaningful contribution only after streamlining by April FY28.

Guidance & Commitments

CommitmentSpecificsTimeline
ATBS volume recoveryMeaningful improvement in volumes, with Q3 already looking strongH2 FY27
Logistics cost tailwindLogistics rates started cooling in Q3, further reduction expected in Q4Q3 and Q4 FY27
FY27 revenue growth20%–25% improvement over previous yearFY27 full year
FY27 EBITDA margin24%–25%FY27 full year
FY28 EBITDA margin25%–26%FY28 full year
VOPL streamliningRe-engineering complete, meaningful top-line and bottom-line contribution beginsApril/May FY28
MEHQ commercial salesCommercial sales begin, ramp-up to optimum utilization within one yearStarting April FY28
First ₹500 cr capex commercializationNew specialty chemicals plants operationalWithin two years
Second ₹500 cr capex decisionClarity after land acquisition and pilot trials completeWithin six months

Key Metrics

MetricQ2 FY27
Standalone net income (incl. other income)₹681 cr, down 4% QoQ from ₹707 cr in Q1 FY27
Standalone net income (incl. other income)₹707 cr, up 21% YoY from ₹562 cr in Q2 FY26
Standalone EBITDA₹142 cr, down 27% YoY from ₹195 cr in Q2 FY26
Standalone PAT₹87 cr, down 33% YoY from ₹129 cr in Q2 FY26
Consolidated net income (incl. other income)₹693 cr, up 23% YoY from ₹566 cr in Q2 FY26, down 2% QoQ from ₹704 cr in Q1 FY27
Consolidated EBITDA₹138 cr, down 24% YoY from ₹183 cr in Q2 FY26
Consolidated PAT₹187 cr (H1 FY27), down 15% YoY from ₹219 cr in H1 FY26
EBITDA margin21%, impacted by ATBS sales shift from Q2 to Q3 and logistics, power costs not fully passed through
FY27 top-line growth guidance20%–25% improvement over FY26
FY27 EBITDA margin guidance24%–25%
FY28 EBITDA margin expectation25%–26%
ATBS revenue share27%–28% of top line (H1 FY27)
IBB revenue share12%–15% of top line (H1 FY27)
Butyl Phenols revenue share16%–20% of top line (H1 FY27)
Antioxidants revenue share15%–17% of top line (H1 FY27)
Announced capex plan₹500 cr for new specialty chemicals, commercialization in two years, funded through internal accruals
Additional capex planned₹500 cr, land acquisition underway, more clarity in next couple of months, funded through internal accruals
New capex expected asset turnover1:1 to 1.5x
New capex expected ROI15%–20%
New products average realization~$3 per kg, range $2–$4.5 per kg
New products export share65%–70%
VOPL revenue expectation for FY27₹75 cr–₹100 cr, will not cross ₹100 cr this financial year